• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Abliva

Less than 1K followers
All
Webcasts
Press releases
3rd party
ShowingAll content types

Press release17.03.2025, 12.05

BioStock: Last trading day for Abliva - the company leaves Nasdaq Stockholm

Abliva
Regulatory press release03.03.2025, 13.10

Delisting of the shares of Abliva: last day of trading 17 March 2025

Abliva
Regulatory press release26.02.2025, 08.30

Notice of Extraordinary General Meeting in Abliva AB (publ)

Abliva

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release25.02.2025, 09.50

Abliva applies for delisting and will convene an extraordinary general meeting

Abliva
Regulatory press release21.02.2025, 08.30

Abliva AB Year-End Report January – December 2024

Abliva
Press release10.02.2025, 10.43

BioStock: Pharming completes bid for Abliva

Abliva
Regulatory press release15.12.2024, 20.00

Statement by the Board of Directors of Abliva regarding the public cash offer from Pharming

Abliva
Press release09.12.2024, 08.32

Abliva Announces Publication of Results from Phase 1a/b Study of KL1333 in the Scientific Journal Brain

Abliva
Press release04.12.2024, 11.34

BioStock: From mutation to solution - Abliva gains ground

Abliva
Regulatory press release29.11.2024, 18.00

Abliva AB Interim Report January – September 2024

Abliva
Press release04.11.2024, 11.00

Abliva will present at the BioStock Life Science Summit, November 21

Abliva
Press release18.09.2024, 09.38

BioStock: Abliva leads the fight against mitochondrial disease

Abliva
Press release16.09.2024, 08.30

Join Abliva for World Mitochondrial Disease Week 2024, September 16 – 22

Abliva
Regulatory press release30.08.2024, 08.30

Amended number of shares and votes in Abliva AB (publ)

Abliva
Press release26.08.2024, 08.46

BioStock: Abliva's CEO - We are the leading programme in mitochondrial disease

Abliva
Regulatory press release22.08.2024, 08.30

Abliva AB Interim Report January – June 2024

Abliva
Press release24.07.2024, 11.57

Abliva's CEO to BioStock: "One step closer to a marketed medicine"

Abliva
Regulatory press release19.07.2024, 08.30

Positive interim analysis in Abliva's FALCON study triggers convertible loan conversion

Abliva
Regulatory press release18.07.2024, 22.22

Abliva Announces Positive Interim Analysis of the FALCON Study for KL1333 in Primary Mitochondrial Disease

Abliva
Regulatory press release31.05.2024, 08.30

Amended number of shares and votes in Abliva AB (publ)

Abliva